Massive dilution and limited R&D spend signal near-term cash concerns. Monitor for further dilutive offerings and clinical trial updates. Expect continued downward pressure on stock as warrants are exercised.
Price Chart
Executive Summary
XORTX closed a $5M public offering of 2.66M common shares/pre-funded warrants at $1.88/share, representing massive dilution relative to its $4M market cap. Half of proceeds ($2.5M) will go to IR marketing, not R&D. This is a dilutive capital raise for a pre-revenue micro-cap biotech.
Key Facts
- $5M gross proceeds from 2,659,574 units at $1.88 per unit
- 183,577 common shares and 2,475,997 pre-funded warrants issued
- $2.5M of proceeds to IR Agency LLC for marketing services
- Offering closed May 19, 2026; registration effective May 13, 2026
- Market cap ~$4M; offering adds ~125% dilution
Financial Impact
125%+ dilution of outstanding shares, net proceeds ~$4.6M after $200k commission
Risk Factors
- Severe dilution depresses per-share value
- Half of proceeds spent on IR, not drug development
- Low market cap increases stock volatility
- No revenue; relies on additional capital raises
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (XRTX) — Batch item 1 | 0001171843-26-003522 |
| Document: f6k_051926.htm | press-3297319 |
| Document: 0001171843-26-003522-index-headers.html | 0001171843-26-003522 |
| Document: 0001171843-26-003522-index.html | 0001171843-26-003522 |
| Document: 0001171843-26-003522.txt | 0001171843-26-003522 |
| PRESS-RELEASE Data (Synthetic) | 0001171843-26-003522 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 17d ago | 6-K | $1.41 | awaiting T+20 | — | $1.07 (−24.11%) |
Sep 18, 2026 5w ago | 6-K | $1.92 $1.24 | ▼ −35.42% | ▼ −35.62% | $1.07 (−44.27%) |
Sep 18, 2026 5w ago | Press Release | $1.92 $1.24 | ▼ −35.42% | ▼ −35.62% | $1.07 (−44.27%) |
Sep 4, 2026 7w ago | 6-K | $2.31 $1.70 | ▲ +26.41% | ▲ +27.01% | $1.07 (+53.68%) |
Aug 28, 2026 8w ago | 6-K | $2.34 $1.71 | ▼ −26.86% | ▼ −27.12% | $1.07 (−54.23%) |
Aug 3, 2026 11w ago | 6-K | $2.16 $2.16 | · 0.00% | ▲ +1.24% | $1.07 (−50.46%) |
Jul 29, 2026 12w ago | 6-K | $2.06 $2.22 | ▲ +7.67% | ▲ +2.65% | $1.07 (−48.06%) |
Jun 15, 2026 19w ago | 6-K | $2.19 $2.03 | ▼ −7.31% | ▼ −6.56% | $1.07 (−51.14%) |
Jun 12, 2026 19w ago | 6-K | $2.19 $2.03 | ▼ −7.31% | ▼ −6.56% | $1.07 (−51.14%) |
May 19, 2026 22w ago | 6-K / PRESS-RELEASE | $2.32 $2.15 | ▲ +7.33% | ▲ +8.31% | $1.07 (+53.88%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers